Dolby Laboratories (DLB) Tops Q2 EPS by 8c; Offers Strong Q3 EPS Guidance

Dolby Laboratories (NYSE: DLB) reported Q2 EPS of $0.72, $0.08 better than the analyst estimate of $0.64. Revenue for the quarter came in at $271.9 million versus the consensus estimate of $265.46 million.

Dolby Laboratories sees Q3 2015 EPS of $0.43-$0.49, versus the consensus of $0.32. Dolby Laboratories sees Q3 2015 revenue of $230-240 million, versus the consensus of $237.1 million.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.

You May Also Be Interested In

• Novartis hikes full-year guidance as Q1 results exceed estimates, shares pop
• Cleveland-Cliffs Q1 results miss estimates on hit from buyers strike
• Alexandria Real Estate (ARE) Tops Q1 EPS by 10c; updates guidance